119 related articles for article (PubMed ID: 8177029)
21. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
[TBL] [Abstract][Full Text] [Related]
22. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of a combination of clonidine and propranolol in conscious cirrhotic rats.
Roulot D; Gaudin C; Braillon A; Sekiyama T; Bacq Y; Lebrec D
Can J Physiol Pharmacol; 1989 Oct; 67(10):1369-72. PubMed ID: 2611730
[TBL] [Abstract][Full Text] [Related]
24. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Chen CF; Hong CY
J Gastroenterol Hepatol; 1997 Aug; 12(8):585-9. PubMed ID: 9304511
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis.
Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1994 Nov; 21(5):779-86. PubMed ID: 7890894
[TBL] [Abstract][Full Text] [Related]
27. Circulatory actions of vasopressin in anaesthetized rats with portal hypertension subjected to haemorrhage.
Valla D; Geoffroy P; Girod C; Lebrec D
J Hepatol; 1986; 2(3):328-39. PubMed ID: 3722788
[TBL] [Abstract][Full Text] [Related]
28. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
29. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
32. The hemodynamic effects of AT-112, an analog of ketanserin, in portal hypertensive rats.
Lin HC; Yang MC; Huang YT; Yu PC; Hou MC; Hong CY; Lee SD
Pharmacology; 1997 Jan; 54(1):16-23. PubMed ID: 9065957
[TBL] [Abstract][Full Text] [Related]
33. Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats.
Moreau R; Komeichi H; Cailmail S; Lebrec D
J Hepatol; 1992 Sep; 16(1-2):215-8. PubMed ID: 1484155
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
Westaby D; Gimson A; Hayes PC; Williams R
Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
[TBL] [Abstract][Full Text] [Related]
35. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
Martikainen TJ; Uusaro A; Tenhunen JJ; Ruokonen E
Acta Anaesthesiol Scand; 2004 Sep; 48(8):935-43. PubMed ID: 15315609
[TBL] [Abstract][Full Text] [Related]
36. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
37. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
[TBL] [Abstract][Full Text] [Related]
38. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726
[TBL] [Abstract][Full Text] [Related]
39. Hyposensitivity to vasopressin in a hemorrhaged-transfused rat model of portal hypertension.
Kravetz D; Cummings SA; Groszmann RJ
Gastroenterology; 1987 Jul; 93(1):170-5. PubMed ID: 3582903
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
